v3.26.1
COMMITMENTS AND CONTINGENCIES
3 Months Ended
Mar. 31, 2026
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES
As of March 31, 2026, the Company had the following commitments to fund various investments:
As of
March 31, 2026
Total loan commitments$375,661,201 
Less: drawn commitments(361,215,505)
Total undrawn commitments$14,445,696 
See below for more information on the Company’s unfunded commitments:
As of
March 31, 2026
Unfunded Commitment Balances
First lien delayed draw term loan:
Theratrue, Inc.$3,029,030 
Standard Wellness Company, LLC1,750,000 
BCIS AH Borrower LLC9,666,666 
Total$14,445,696 
As of December 31, 2025, the Company had the following commitments to fund various investments pre-Conversion:
As of
December 31, 2025
Total loan commitments$332,631,207 
Less: drawn commitments(322,339,968)
Total undrawn commitments$10,291,239 
See below for more information on the Company’s unfunded commitments pre-Conversion:
As of
December 31, 2025
Unfunded Commitment Balances
First lien delayed draw term loan:
Theratrue, Inc.$3,520,374 
Gron Holdings, Inc.5,141,110 
Standard Wellness Company, LLC1,629,755 
Total$10,291,239 
The Company from time to time may be a party to litigation or other legal proceedings relating to claims arising from the ordinary course of business. Refer to Part II. Item 1 – Legal Proceedings for information regarding certain material developments in pending litigation during the quarter ended March 31, 2026. The Company is required to establish reserves for litigation matters where those matters present loss contingencies that are both probable and estimable. When loss contingencies are not both probable and estimable, we do not establish reserves. Because each of these actions are in their early stages, no reasonable estimate of possible outcomes resulting from these legal actions can be made at this time.
Historically, the Company provided loans to companies operating in the cannabis industry which involved significant risks, including the risk of strict enforcement against the Company’s borrowers on the federal illegality of cannabis, the Company’s borrowers’ inability to renew or otherwise maintain their licenses or other requisite authorizations for their
cannabis operations, and such loans lack of liquidity, and the Company could lose all or part of any of the Company’s loans.
The Company’s ability to grow or maintain its business with respect to the loans it makes to companies operating in the cannabis industry depends on state laws pertaining to the cannabis industry. New laws that are adverse to the Company’s borrowers may be enacted, and current favorable state or national laws or enforcement guidelines relating to cultivation, production and distribution of cannabis may be modified or eliminated in the future, which would impede the Company’s ability to grow and could materially adversely affect the Company’s business.
Management’s plan to mitigate risks include monitoring the legal landscape as deemed appropriate. Also, should a loan default or otherwise be seized, the Company may be prohibited from owning cannabis assets and thus could not take possession of collateral, in which case the Company would look to sell the loan, which could result in the Company realizing a loss on the transaction.